Enovis ( (ENOV) ) has provided an update.
Enovis Corporation announced the appointment of Damien McDonald as its new Chief Executive Officer, effective May 12, 2025, succeeding Matt Trerotola who will retire but remain as an Executive Advisor for a year. McDonald, with over 35 years in the medical device industry, previously served as CEO of LivaNova and will join the Enovis Board following the 2025 Annual Meeting. The company also reaffirmed its first quarter revenue and adjusted EBITDA expectations, indicating stability and continuity in its strategic direction.
More about Enovis
Enovis Corporation is an innovation-driven medical technology growth company focused on developing clinically differentiated solutions to improve patient outcomes and transform workflows. The company offers a wide range of products, services, and integrated technologies, primarily in the orthopedics sector, and is listed on the New York Stock Exchange under the symbol ENOV.
YTD Price Performance: -16.07%
Average Trading Volume: 978,531
Technical Sentiment Signal: Buy
Current Market Cap: $2.18B
Learn more about ENOV stock on TipRanks’ Stock Analysis page.